$29.05
0.65% yesterday
NYSE, Jun 11, 10:10 pm CET
ISIN
US2289031005
Symbol
AORT

CryoLife Stock price

$29.05
+0.28 0.97% 1M
-0.87 2.91% 6M
+0.46 1.61% YTD
+5.65 24.15% 1Y
+7.10 32.35% 5Y
+17.88 160.07% 10Y
+21.49 284.26% 20Y
NYSE, Closing price Wed, Jun 11 2025
-0.19 0.65%
ISIN
US2289031005
Symbol
AORT
Sector

Key metrics

Market capitalization $1.24b
Enterprise Value $1.52b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 3.90
P/S ratio (TTM) P/S ratio 3.18
P/B ratio (TTM) P/B ratio 4.22
Revenue growth (TTM) Revenue growth 5.94%
Revenue (TTM) Revenue $390.08m
EBIT (operating result TTM) EBIT $21.11m
Free Cash Flow (TTM) Free Cash Flow $-440.00k
Cash position $37.69m
EPS (TTM) EPS $-0.51
P/E forward 260.15
P/S forward 2.90
EV/Sales forward 3.56
Short interest 12.78%
Show more

Is CryoLife a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,842 stocks worldwide.

CryoLife Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a CryoLife forecast:

6x Buy
100%

Analyst Opinions

6 Analysts have issued a CryoLife forecast:

Buy
100%

Financial data from CryoLife

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
390 390
6% 6%
100%
- Direct Costs 141 141
8% 8%
36%
249 249
5% 5%
64%
- Selling and Administrative Expenses 187 187
9% 9%
48%
- Research and Development Expense 28 28
1% 1%
7%
37 37
5% 5%
9%
- Depreciation and Amortization 16 16
1% 1%
4%
EBIT (Operating Income) EBIT 21 21
9% 9%
5%
Net Profit -21 -21
123% 123%
-5%

In millions USD.

Don't miss a Thing! We will send you all news about CryoLife directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CryoLife Stock News

Neutral
PRNewsWire
9 days ago
ATLANTA , June 3, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investors conferences. Artivion's management team will present at the upcoming Truist Securities MedTech Conference on Tuesday, June 17, 2025, at the InterContinental Boston Hotel.
Neutral
PRNewsWire
15 days ago
ATLANTA , May 28, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the closing of transactions related to previously announced, privately negotiated exchange agreements with certain holders (the "Holders") of its 4.250% Convertible Senior Notes due 2025 (the "Notes"). The closing transactions included the...
Neutral
PRNewsWire
29 days ago
ATLANTA , May 14, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it entered into separate, privately negotiated exchange agreements with certain holders of its 4.250% Convertible Senior Notes due 2025 (the "Existing Convertible Notes"). Under the exchange agreements, the company will, subject to cu...
More CryoLife News

Company Profile

CryoLife, Inc. engages in the manufacture, process and distribution of medical devices. It operates through the following segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of BioGlue; JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PerClot and PhotoFix. The Preservation Services segment focuses on external services revenues from the preservation of cardiac and vascular tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.

Head office United States
CEO James Mackin
Employees 1,600
Founded 1984
Website artivion.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today